Cartalax: What It Is & Research Status

Type: Short peptide (bioregulator)
Research area: Bioregulator peptides
Research stage: Laboratory research; limited clinical use outside the U.S.
FDA status: Not an FDA-approved medicine

About Cartalax

A short bioregulator peptide studied mostly in Russian laboratory research related to cartilage.

Where the research stands

Most published work on this compound comes from laboratory, animal or early human studies. Results in those settings don't always carry over to people, and long-term safety data are limited.

Read the studies

PubMed ↗ClinicalTrials.gov ↗

Educational information only; not medical advice. Talk to a licensed doctor before using any compound.

Common questions

Is Cartalax an FDA-approved medicine?

No. Cartalax is not an FDA-approved medicine. Research stage: Laboratory research; limited clinical use outside the U.S..

Does EKO Labs sell Cartalax?

No. EKO Labs does not sell Cartalax or any research compound. This library is for education only. EKO Labs offers FDA-approved prescription treatments only after a licensed doctor decides they are right for you.

Can people use Cartalax?

This page does not cover personal use. Products labeled "research use only" are not made or approved for people. Ask a licensed doctor before using any compound.

What is the molecular formula of Cartalax?

According to PubChem (U.S. National Library of Medicine), Cartalax has the molecular formula C12H19N3O8 and a molar mass of about 333.3 g/mol.